Morgan Stanley’s ProQR Therapeutics PRQR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.29M Buy
3,083,490
+1,699,997
+123% +$3.47M ﹤0.01% 3860
2025
Q1
$1.84M Buy
1,383,493
+897,508
+185% +$1.19M ﹤0.01% 4657
2024
Q4
$1.29M Buy
485,985
+211,535
+77% +$561K ﹤0.01% 4957
2024
Q3
$499K Buy
274,450
+196,508
+252% +$358K ﹤0.01% 5409
2024
Q2
$129K Buy
77,942
+10,351
+15% +$17.2K ﹤0.01% 5869
2024
Q1
$155K Sell
67,591
-159,831
-70% -$366K ﹤0.01% 5817
2023
Q4
$450K Sell
227,422
-115,536
-34% -$229K ﹤0.01% 5661
2023
Q3
$446K Sell
342,958
-152,558
-31% -$198K ﹤0.01% 5222
2023
Q2
$803K Sell
495,516
-153,342
-24% -$248K ﹤0.01% 4957
2023
Q1
$1.38M Buy
648,858
+270,208
+71% +$576K ﹤0.01% 4679
2022
Q4
$1.4M Sell
378,650
-99,063
-21% -$367K ﹤0.01% 4678
2022
Q3
$355K Buy
477,713
+78,918
+20% +$58.6K ﹤0.01% 5444
2022
Q2
$311K Buy
398,795
+196,891
+98% +$154K ﹤0.01% 5665
2022
Q1
$183K Buy
201,904
+165,283
+451% +$150K ﹤0.01% 5977
2021
Q4
$293K Sell
36,621
-74,449
-67% -$596K ﹤0.01% 5860
2021
Q3
$930K Sell
111,070
-273,802
-71% -$2.29M ﹤0.01% 5093
2021
Q2
$2.59M Sell
384,872
-95,691
-20% -$645K ﹤0.01% 4432
2021
Q1
$3.18M Sell
480,563
-533,512
-53% -$3.53M ﹤0.01% 3873
2020
Q4
$4.26M Buy
1,014,075
+798,966
+371% +$3.36M ﹤0.01% 3430
2020
Q3
$1.03M Sell
215,109
-174,769
-45% -$838K ﹤0.01% 4199
2020
Q2
$2.37M Buy
389,878
+186,396
+92% +$1.13M ﹤0.01% 3438
2020
Q1
$1.12M Buy
203,482
+201,816
+12,114% +$1.11M ﹤0.01% 3871
2019
Q4
$17K Sell
1,666
-705
-30% -$7.19K ﹤0.01% 6141
2019
Q3
$14K Buy
2,371
+367
+18% +$2.17K ﹤0.01% 6112
2019
Q2
$18K Sell
2,004
-76,453
-97% -$687K ﹤0.01% 5971
2019
Q1
$1.09M Sell
78,457
-235,538
-75% -$3.27M ﹤0.01% 4049
2018
Q4
$4.96M Sell
313,995
-92,289
-23% -$1.46M ﹤0.01% 2917
2018
Q3
$7.86M Buy
406,284
+115,709
+40% +$2.24M ﹤0.01% 2675
2018
Q2
$2.12M Buy
290,575
+60,575
+26% +$442K ﹤0.01% 4029
2018
Q1
$707K Buy
230,000
+52,400
+30% +$161K ﹤0.01% 4789
2017
Q4
$573K Buy
177,600
+76,300
+75% +$246K ﹤0.01% 4894
2017
Q3
$491K Buy
101,300
+39,428
+64% +$191K ﹤0.01% 4890
2017
Q2
$322K Buy
61,872
+13,319
+27% +$69.3K ﹤0.01% 5065
2017
Q1
$243K Sell
48,553
-3,458
-7% -$17.3K ﹤0.01% 5224
2016
Q4
$255K Buy
52,011
+18,211
+54% +$89.3K ﹤0.01% 5257
2016
Q3
$226K Buy
33,800
+3,500
+12% +$23.4K ﹤0.01% 4956
2016
Q2
$147K Buy
30,300
+29,300
+2,930% +$142K ﹤0.01% 5072
2016
Q1
$5K Buy
+1,000
New +$5K ﹤0.01% 6284
2015
Q4
Sell
-33,516
Closed -$488K 6757
2015
Q3
$488K Sell
33,516
-3,955
-11% -$57.6K ﹤0.01% 4624
2015
Q2
$625K Sell
37,471
-8,899
-19% -$148K ﹤0.01% 4547
2015
Q1
$1.02M Buy
46,370
+4,799
+12% +$105K ﹤0.01% 4120
2014
Q4
$901K Buy
41,571
+25,726
+162% +$558K ﹤0.01% 4231
2014
Q3
$272K Buy
+15,845
New +$272K ﹤0.01% 4969